- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01557738
Role of Flavanols in Exercise and Aging
24 de junio de 2014 actualizado por: Robert M. Brothers, University of Texas at Austin
Acute and Long-term Effects of Dietary Flavanols on Local Control of Skeletal Muscle Blood Flow During Exercise in Young and Old Humans
It has well known that diets rich in fruits, vegetables and cocoa products are associated with positive health benefits and these positive effects have been shown to be due to compounds they contain called flavanols.
Flavanols have been shown to exert their positive effects by indirectly increasing nitric oxide (NO) bioavailability.
NO is a potent vasodilator that is believed to play a role in increasing blood flow to active muscle during exercise.
This regulatory process is impaired with healthy aging.
The underlying premise to this study is that if NO bioavailability can be increased following flavanol ingestion, will there be a restoration of blood flow during exercise in older individuals?
Accordingly, the first part of this research project will compare the acute vascular effects of flavanol ingestion between a young and old group.
The investigators have hypothesized that both groups will show an improvement in blood flow to active muscle during exercise, though the magnitude of the change will be greater in the older group.
The second part of this project will look at the effects of 4 weeks of daily flavanol ingestion in the old group.
The investigators hypothesize that subjects will demonstrate an improvement in blood flow to active muscle during exercise after the 4 week intervention and that the magnitude of the change will be greater than the acute effects.
Findings from this proposal will provide evidence for the efficacy of flavanols to be used (as a simple and safe lifestyle intervention) to reverse or combat impaired blood flow regulation in older individuals.
Descripción general del estudio
Estado
Terminado
Condiciones
Tipo de estudio
Intervencionista
Inscripción (Actual)
20
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Texas
-
Austin, Texas, Estados Unidos, 78712
- University of Texas at Austin: Environmental and Autonomic Physiology Laboratory
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 80 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Males and Females between 18 - 30 years old
- Males and Females between 60 - 80 years old
Exclusion Criteria:
- cardiovascular and/or microvascular disease
- blood clotting disorder
- pregnant lady
- current smoker (or regularly smoked within last year)
- a history of an adverse reaction to cold
- taking medications known to effect the autonomic nervous system
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Acute effects of flavanol consumption
The outcome measurements will be made on all study participants before and 2 hours after consumption of the high flavanol beverage.
|
The experimental trial (high flavanol content) will involve the consumption of a beverage containing about 1000mg of cocoa flavanols.
|
|
Comparador de placebos: Low Flavanol Trial; acute effects
Once again, the outcome measurements will be made on all study participants before and 2 hours after consumption of the low flavanol beverage.
|
The placebo trial (low flavanol content) will involve the consumption of a beverage containing 75 mg of cocoa flavanols.
|
|
Experimental: Long-term effects of flavanol consumption
Only those study participants over 60 years of age will continue with this arm of the trial.
The same outcome measures will be performed following 4 weeks of daily consumption of a high flavanol beverage.
|
The experimental trial (high flavanol content) will involve the daily consumption of a beverage containing about 1000mg of cocoa flavanols for 4 weeks.
Subjects will be provided with 28 packets of the beverage to take home with them.
|
|
Comparador de placebos: Low Flavanol Trial; long-term effects
Only those study participants over 60 years of age will continue with this arm of the trial.
The same outcome measures will be performed following 4 weeks of daily consumption of a low flavanol beverage.
|
The placebo trial (low flavanol content) will involve the daily consumption of a beverage containing 75 mg of cocoa flavanols for 4 weeks.
Subjects will be provided with 28 packets to take home with them.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in femoral blood flow during exercise following flavanol consumption
Periodo de tiempo: During knee extension exercise, change from baseline in blood flow 2 hours post flavanol ingestion
|
Blood flow regulation to active muscles during knee extension exercise can be assessed by using ultrasound to measure blood flow in the femoral artery.
This will be done before and after stimulation of the sympathetic nervous system.
A baseline value will be obtained and then the measurement will be performed again 2 hours after flavanol ingestion.
|
During knee extension exercise, change from baseline in blood flow 2 hours post flavanol ingestion
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in flow-mediated dilation (FMD) following flavanol consumption
Periodo de tiempo: Change from baseline in FMD 2 hours post flavanol ingestion
|
Flow-mediated dilation is commonly used as an index of nitric oxide bioavailability.
Nitric oxide is believed to play a role in blood flow regulation during exercise.
A baseline value will be obtained and then the measurement will be performed again 2 hours after flavanol ingestion.
|
Change from baseline in FMD 2 hours post flavanol ingestion
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Michelle Harrison, M.A., University of Texas at Austin
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de diciembre de 2012
Finalización primaria (Actual)
1 de abril de 2014
Finalización del estudio (Actual)
1 de abril de 2014
Fechas de registro del estudio
Enviado por primera vez
8 de marzo de 2012
Primero enviado que cumplió con los criterios de control de calidad
15 de marzo de 2012
Publicado por primera vez (Estimar)
19 de marzo de 2012
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
25 de junio de 2014
Última actualización enviada que cumplió con los criterios de control de calidad
24 de junio de 2014
Última verificación
1 de mayo de 2014
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 2012-02-0114
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .